{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:57:46Z","timestamp":1769824666860,"version":"3.49.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Disruption of nicotinamide adenine dinucleotide (NAD) biosynthesis and function during infection may impair host defenses and aggravate inflammatory and oxidative organ injury. Increasingly, studies are investigating whether niacin or NAD metabolite treatment is beneficial in infection and sepsis animal models. We examined whether this preclinical experience supports clinical trials. A systematic review of three data bases was conducted through 2\/29\/2024 and a meta-analysis was performed comparing niacin or NAD metabolite treatment to control in adult animal models employing microbial challenges. Fifty-six studies met inclusion criteria, with 24 published after 2019. Most studies employed mouse (n\u2009=\u200940 studies) or rat (n\u2009=\u200912) models and administered either a bacterial toxin (n\u2009=\u200928) or bacterial (n\u2009=\u200919) challenge. Four and three studies employed viral or fungal challenges respectively. Studies investigated an NAD metabolite alone (n\u2009=\u200944), niacin alone (n\u2009=\u20099), or both (n\u2009=\u20093), usually administered before or within 24h after challenge (n\u2009=\u200950). Only three and four studies included standard antimicrobial support or started treatment\u2009&gt;\u200924h after challenge respectively. In similar patterns with differing animal types (p\u2009\u2265\u20090.06), compared to control across those studies investigating the parameter, niacin or NAD treatment decreased the odds ratio of mortality [95% confidence interval (CI)] [0.28 (0.17, 0.49)] and in blood or tissue increased antioxidant levels [standardized mean differences (95%CI)] (SMD) [3.61 (2.20,5.02)] and decreased levels of microbes [\u2212\u00a02.44 (\u2212\u00a03.34, \u2212\u00a01.55)], histologic and permeability organ injury scoring [\u2212\u00a01.62 (\u2212\u00a02.27, \u2212\u00a00.98) and \u2212\u00a01.31(\u2212\u00a01.77, \u2212\u00a00.86) respectively], levels of TNF\u03b1, IL-6 and IL-1\u03b2 [\u2212\u00a02.47 (\u2212\u00a03.30, \u2212\u00a01.64), \u2212\u00a03.17 (\u2212\u00a04.74, \u2212\u00a01.60) and \u2212\u00a08.44 (\u2212\u00a012.4, \u2212\u00a04.5) respectively] and myeloperoxidase (MPO) [\u2212\u00a01.60 (\u2212\u00a02.06, \u2212\u00a01.14)], although with significant, primarily quantitative heterogeneity for each (I<jats:sup>2<\/jats:sup>\u2009\u2265\u200953%, p\u2009&lt;\u20090.01) except MPO. Treatment increased blood or tissue NAD<jats:sup>+<\/jats:sup> levels and decreased chemical organ injury measures and oxidation markers but differently comparing species (p\u2009\u2264\u20090.05). Only 2 and 9 survival studies described power analyses or animal randomization respectively and no study described treatment or non-histologic outcome measure blinding. Among survival studies, Egger\u2019s analysis (p\u2009=\u20090.002) suggested publication bias. While suggestive, published animal studies do not yet support clinical trials testing niacin and NAD metabolite treatment for infection and sepsis. Animal studies simulating clinical conditions and with randomized, blinded designs are needed to investigate this potentially promising therapeutic approach.<\/jats:p>","DOI":"10.1038\/s41598-025-95735-y","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T10:30:26Z","timestamp":1744453826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant models"],"prefix":"10.1038","volume":"15","author":[{"given":"Colleen S.","family":"Curran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xizhong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Minkove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia A.","family":"Livinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Q.","family":"Eichacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parizad","family":"Torabi-Parizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"10219","key":"95735_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study. Lancet 395(10219), 200\u2013211 (2020).","journal-title":"Lancet"},{"key":"95735_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154096","volume":"71","author":"M van den Berg","year":"2022","unstructured":"van den Berg, M., van Beuningen, F. E., Ter Maaten, J. C. & Bouma, H. R. Hospital-related costs of sepsis around the world: A systematic review exploring the economic burden of sepsis. J. Crit. Care 71, 154096 (2022).","journal-title":"J. Crit. Care"},{"issue":"11","key":"95735_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.34290","volume":"4","author":"C Fleischmann-Struzek","year":"2021","unstructured":"Fleischmann-Struzek, C. et al. Epidemiology and costs of postsepsis morbidity, nursing care dependency, and mortality in Germany, 2013 to 2017. JAMA Netw. Open 4(11), e2134290 (2021).","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"95735_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10020-019-0132-z","volume":"26","author":"Z Mostel","year":"2019","unstructured":"Mostel, Z. et al. Post-sepsis syndrome - an evolving entity that afflicts survivors of sepsis. Mol. Med. 26(1), 6 (2019).","journal-title":"Mol. Med."},{"key":"95735_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101195","volume":"49","author":"S Amjad","year":"2021","unstructured":"Amjad, S. et al. Role of NAD(+) in regulating cellular and metabolic signaling pathways. Mol. Metab. 49, 101195 (2021).","journal-title":"Mol. Metab."},{"issue":"2","key":"95735_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4049\/jimmunol.2200552","volume":"211","author":"CS Curran","year":"2023","unstructured":"Curran, C. S. et al. Nicotinamide antagonizes lipopolysaccharide-induced hypoxic cell signals in human macrophages. J. Immunol. 211(2), 261\u2013273 (2023).","journal-title":"J. Immunol."},{"issue":"1","key":"95735_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12871-022-01718-1","volume":"22","author":"C Bime","year":"2022","unstructured":"Bime, C. et al. Circulating eNAMPT as a biomarker in the critically ill: acute pancreatitis, sepsis, trauma, and acute respiratory distress syndrome. BMC Anesthesiol. 22(1), 182 (2022).","journal-title":"BMC Anesthesiol."},{"issue":"2","key":"95735_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/0310057X1003800213","volume":"38","author":"JP Zeden","year":"2010","unstructured":"Zeden, J. P. et al. Excessive tryptophan catabolism along the kynurenine pathway precedes ongoing sepsis in critically ill patients. Anaesth. Intensive Care 38(2), 307\u2013316 (2010).","journal-title":"Anaesth. Intensive Care"},{"key":"95735_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883628","volume":"13","author":"G Lu","year":"2022","unstructured":"Lu, G. et al. Landscape of metabolic fingerprinting for diagnosis and risk stratification of sepsis. Front. Immunol. 13, 883628 (2022).","journal-title":"Front. Immunol."},{"issue":"19","key":"95735_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019906","volume":"99","author":"G Troche","year":"2020","unstructured":"Troche, G. et al. Tryptophan pathway catabolites (serotonin, 5-hydroxyindolacetic acid, kynurenine) and enzymes (monoamine oxidase and indole amine 2,3 dioxygenase) in patients with septic shock: A prospective observational study versus healthy controls. Medicine (Baltimore) 99(19), e19906 (2020).","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"95735_CR11","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/jcmm.17222","volume":"26","author":"S He","year":"2022","unstructured":"He, S. et al. NAD(+) ameliorates endotoxin-induced acute kidney injury in a sirtuin1-dependent manner via GSK-3beta\/Nrf2 signalling pathway. J. Cell. Mol. Med. 26(7), 1979\u20131993 (2022).","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"95735_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/13880209.2023.2292256","volume":"62","author":"S He","year":"2024","unstructured":"He, S. et al. Nicotinamide mononucleotide alleviates endotoxin-induced acute lung injury by modulating macrophage polarization via the SIRT1\/NF-kappaB pathway. Pharm. Biol. 62(1), 22\u201332 (2024).","journal-title":"Pharm. Biol."},{"issue":"1","key":"95735_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41421-022-00409-y","volume":"8","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Treatment of SARS-CoV-2-induced pneumonia with NAD(+) and NMN in two mouse models. Cell Discov. 8(1), 38 (2022).","journal-title":"Cell Discov."},{"issue":"2","key":"95735_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/CCM.0b013e3181feeae4","volume":"39","author":"WY Kwon","year":"2011","unstructured":"Kwon, W. Y., Suh, G. J., Kim, K. S. & Kwak, Y. H. Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-kappaB pathway. Crit. Care Med. 39(2), 328\u2013334 (2011).","journal-title":"Crit. Care Med."},{"key":"95735_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102745","volume":"63","author":"HR Li","year":"2023","unstructured":"Li, H. R. et al. beta-Nicotinamide mononucleotide activates NAD+\/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice. Redox Biol. 63, 102745 (2023).","journal-title":"Redox Biol."},{"issue":"6","key":"95735_CR16","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1183\/09031936.94.07061125","volume":"7","author":"A Nagai","year":"1994","unstructured":"Nagai, A., Yasui, S., Ozawa, Y., Uno, H. & Konno, K. Niacin attenuates acute lung injury induced by lipopolysaccharide in the hamster. Eur. Respir. J. 7(6), 1125\u20131130 (1994).","journal-title":"Eur. Respir. J."},{"issue":"2","key":"95735_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/jnc.15367","volume":"158","author":"J Roboon","year":"2021","unstructured":"Roboon, J. et al. Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD(). J Neurochem 158(2), 311\u2013327 (2021).","journal-title":"J Neurochem"},{"issue":"4","key":"95735_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1086\/367544","volume":"36","author":"MF Murray","year":"2003","unstructured":"Murray, M. F. Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus. Clin. Infect. Dis. 36(4), 453\u2013460 (2003).","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"95735_CR19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/mnfr.201300818","volume":"58","author":"D Bettenworth","year":"2014","unstructured":"Bettenworth, D. et al. Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance. Mol. Nutr. Food Res. 58(7), 1474\u20131490 (2014).","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"95735_CR20","doi-asserted-by":"publisher","first-page":"L354","DOI":"10.1152\/ajplung.00198.2010","volume":"300","author":"CA Fernandes","year":"2011","unstructured":"Fernandes, C. A. et al. Nicotinamide enhances apoptosis of G(M)-CSF-treated neutrophils and attenuates endotoxin-induced airway inflammation in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 300(3), L354-361 (2011).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"95735_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2018.05.073","volume":"123","author":"G Hong","year":"2018","unstructured":"Hong, G. et al. Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis. Free Radic. Biol. Med. 123, 125\u2013137 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"95735_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.895028","volume":"9","author":"C Cros","year":"2022","unstructured":"Cros, C. et al. Nicotinamide mononucleotide administration triggers macrophages reprogramming and alleviates inflammation during sepsis induced by experimental peritonitis. Front. Mol. Biosci. 9, 895028 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"95735_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans, C. R. et al. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med. Res. Methodol. 14, 43 (2014).","journal-title":"BMC Med. Res. Methodol."},{"issue":"6","key":"95735_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/0023677217705912","volume":"51","author":"KE Wever","year":"2017","unstructured":"Wever, K. E., Geessink, F. J., Brouwer, M. A. E., Tillema, A. & Ritskes-Hoitinga, M. A systematic review of discomfort due to toe or ear clipping in laboratory rodents. Lab. Anim. 51(6), 583\u2013600 (2017).","journal-title":"Lab. Anim."},{"issue":"3","key":"95735_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 7(3), 177\u2013188 (1986).","journal-title":"Control Clin. Trials"},{"issue":"11","key":"95735_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21(11), 1539\u20131558 (2002).","journal-title":"Stat. Med."},{"key":"95735_CR27","unstructured":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria R Core Team. https:\/\/www.R-project.org\/ (2024)."},{"issue":"4","key":"95735_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi, S., Rucker, G. & Schwarzer, G. How to perform a meta-analysis with R: a practical tutorial. Evid. Based Ment. Health 22(4), 153\u2013160 (2019).","journal-title":"Evid. Based Ment. Health"},{"key":"95735_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110720","volume":"123","author":"NO Abdel Rasheed","year":"2023","unstructured":"Abdel Rasheed, N. O., Shiha, N. A., Mohamed, S. S. & Ibrahim, W. W. SIRT1\/PARP-1\/NLRP3 cascade as a potential target for niacin neuroprotective effect in lipopolysaccharide-induced depressive-like behavior in mice. Int. Immunopharmacol. 123, 110720 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"95735_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1186\/s12967-023-04767-3","volume":"21","author":"T Cao","year":"2023","unstructured":"Cao, T. et al. Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis. J. Transl. Med. 21(1), 883 (2023).","journal-title":"J. Transl. Med."},{"issue":"3","key":"95735_CR31","first-page":"331","volume":"22","author":"YT Chang","year":"1954","unstructured":"Chang, Y. T. Chemotherapy of murine leprosy. III. The effects of nicotinamide and pyrazinamide (aldinamide) on mouse leprosy. Int. J. Lepr. 22(3), 331\u2013346 (1954).","journal-title":"Int. J. Lepr."},{"issue":"1","key":"95735_CR32","first-page":"121","volume":"28","author":"SB Doganay","year":"2022","unstructured":"Doganay, S. B. et al. Antioxidant and anti-inflammatory effects of nicotinamide adenine dinucleotide (NAD+) against acute hepatorenal oxidative injury in an experimental sepsis model. Kafkas Univ. Vet Fak Derg 28(1), 121\u2013130 (2022).","journal-title":"Kafkas Univ. Vet Fak Derg"},{"issue":"14","key":"95735_CR33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1177\/15353702221094235","volume":"247","author":"SH Du","year":"2022","unstructured":"Du, S. H. et al. Nicotinamide mononucleotide ameliorates acute lung injury by inducing mitonuclear protein imbalance and activating the UPR(mt). Exp. Biol. Med. (Maywood) 247(14), 1264\u20131276 (2022).","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"5","key":"95735_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5483\/BMBRep.2023-0030","volume":"56","author":"S Duan","year":"2023","unstructured":"Duan, S., Kim, S. G., Lim, H. J., Song, H. R. & Han, M. K. Interferon-beta alleviates sepsis by SIRT1-mediated blockage of endothelial glycocalyx shedding. BMB Rep. 56(5), 314\u2013319 (2023).","journal-title":"BMB Rep."},{"issue":"1","key":"95735_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0165-2478(97)00088-6","volume":"59","author":"M Fukuzawa","year":"1997","unstructured":"Fukuzawa, M. et al. Inhibitory effect of nicotinamide on in vitro and in vivo production of tumor necrosis factor-alpha. Immunol. Lett. 59(1), 7\u201311 (1997).","journal-title":"Immunol. Lett."},{"key":"95735_CR36","first-page":"17","volume":"25","author":"RL Fulton","year":"1974","unstructured":"Fulton, R. L. Prevention of endotoxic death with nicotinamide and adenosine triphosphate. Surg. Forum 25, 17\u201319 (1974).","journal-title":"Surg. Forum"},{"issue":"2","key":"95735_CR37","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/iai.25.2.538-557.1979","volume":"25","author":"SE Greisman","year":"1979","unstructured":"Greisman, S. E., DuBuy, J. B. & Woodward, C. L. Experimental gram-negative bacterial sepsis: Prevention of mortality not preventable by antibiotics alone. Infect. Immun. 25(2), 538\u2013557 (1979).","journal-title":"Infect. Immun."},{"issue":"9","key":"95735_CR38","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.3390\/ijms21093321","volume":"21","author":"W Guo","year":"2020","unstructured":"Guo, W. et al. Niacin alleviates dairy cow mastitis by regulating the GPR109A\/AMPK\/NRF2 signaling pathway. Int. J. Mol. Sci. 21(9), 3321 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"95735_CR39","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.7150\/ijbs.62380","volume":"17","author":"W Guo","year":"2021","unstructured":"Guo, W. et al. GPR109A alleviate mastitis and enhances the blood milk barrier by activating AMPK\/Nrf2 and autophagy. Int. J. Biol. Sci. 17(15), 4271\u20134284 (2021).","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"95735_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1124\/jpet.103.056556","volume":"307","author":"X Han","year":"2003","unstructured":"Han, X. et al. NAD+ ameliorates inflammation-induced epithelial barrier dysfunction in cultured enterocytes and mouse ileal mucosa. J. Pharmacol. Exp. Ther. 307(2), 443\u2013449 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"95735_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12974-023-02762-5","volume":"20","author":"D He","year":"2023","unstructured":"He, D. et al. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models. J. Neuroinflamm. 20(1), 86 (2023).","journal-title":"J. Neuroinflamm."},{"issue":"46","key":"95735_CR42","doi-asserted-by":"publisher","first-page":"75698","DOI":"10.18632\/oncotarget.12359","volume":"7","author":"M He","year":"2016","unstructured":"He, M. et al. SIRT1-mediated downregulation of p27Kip1 is essential for overcoming contact inhibition of Kaposi\u2019s sarcoma-associated herpesvirus transformed cells. Oncotarget 7(46), 75698\u201375711 (2016).","journal-title":"Oncotarget"},{"issue":"12","key":"95735_CR43","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/00005373-197612000-00005","volume":"16","author":"JG Hilton","year":"1976","unstructured":"Hilton, J. G. & Wells, C. H. Effects of indomethacin and nicotinic acid on E. coli endotoxin shock in anesthetized dogs. J Trauma 16(12), 968\u2013973 (1976).","journal-title":"J Trauma"},{"issue":"4","key":"95735_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bbrc.2019.01.110","volume":"510","author":"K Imaruoka","year":"2019","unstructured":"Imaruoka, K. et al. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL\/lpr mice treated with lipopolysaccharide. Biochem. Biophys. Res. Commun. 510(4), 587\u2013593 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"95735_CR45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88686","author":"J Iske","year":"2024","unstructured":"Iske, J. et al. NAD(+) prevents septic shock-induced death by non-canonical inflammasome blockade and IL-10 cytokine production in macrophages. Elife https:\/\/doi.org\/10.7554\/eLife.88686 (2024).","journal-title":"Elife"},{"key":"95735_CR46","doi-asserted-by":"publisher","first-page":"1158455","DOI":"10.3389\/fimmu.2023.1158455","volume":"14","author":"A Izadpanah","year":"2023","unstructured":"Izadpanah, A. et al. SARS-CoV-2 infection dysregulates NAD metabolism. Front. Immunol. 14, 1158455 (2023).","journal-title":"Front. Immunol."},{"issue":"3","key":"95735_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/FJC.0b013e3180cbd18a","volume":"50","author":"SJ Kao","year":"2007","unstructured":"Kao, S. J., Liu, D. D., Su, C. F. & Chen, H. I. Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin. J. Cardiovasc. Pharmacol. 50(3), 333\u2013342 (2007).","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"95735_CR48","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1097\/CCM.0000000000001422","volume":"44","author":"WY Kwon","year":"2016","unstructured":"Kwon, W. Y. et al. Niacin and selenium attenuate sepsis-induced lung injury by up-regulating nuclear factor erythroid 2-related factor 2 signaling. Crit. Care Med. 44(6), e370-382 (2016).","journal-title":"Crit. Care Med."},{"issue":"1","key":"95735_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0300-483X(95)03202-Q","volume":"107","author":"RD LeClaire","year":"1996","unstructured":"LeClaire, R. D., Kell, W., Bavari, S., Smith, T. J. & Hunt, R. E. Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicity. Toxicology 107(1), 69\u201381 (1996).","journal-title":"Toxicology"},{"issue":"3","key":"95735_CR50","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00705-015-2712-8","volume":"161","author":"WY Li","year":"2016","unstructured":"Li, W. Y. et al. The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo. Arch. Virol. 161(3), 621\u2013630 (2016).","journal-title":"Arch. Virol."},{"key":"95735_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2024.01.046","volume":"214","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Supplementation of nicotinamide mononucleotide diminishes COX-2 associated inflammatory responses in macrophages by activating kynurenine\/AhR signaling. Free Radic. Biol. Med. 214, 69\u201379 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"95735_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00592-18","author":"SN Micheva-Viteva","year":"2019","unstructured":"Micheva-Viteva, S. N. et al. Increased mortality in mice following immunoprophylaxis therapy with high dosage of nicotinamide in burkholderia persistent infections. Infect. Immun. https:\/\/doi.org\/10.1128\/IAI.00592-18 (2019).","journal-title":"Infect. Immun."},{"key":"95735_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104877","volume":"98","author":"Y Mo","year":"2023","unstructured":"Mo, Y. et al. Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice. EBioMedicine 98, 104877 (2023).","journal-title":"EBioMedicine"},{"issue":"1","key":"95735_CR54","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1038\/s41467-023-40545-x","volume":"14","author":"HT Pacl","year":"2023","unstructured":"Pacl, H. T. et al. NAD(H) homeostasis underlies host protection mediated by glycolytic myeloid cells in tuberculosis. Nat. Commun. 14(1), 5472 (2023).","journal-title":"Nat. Commun."},{"key":"95735_CR55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jss.2022.12.020","volume":"285","author":"H Park","year":"2023","unstructured":"Park, H. et al. Combination therapy of niacin and apocynin attenuates lung injury during sepsis in rats. J. Surg. Res. 285, 51\u201358 (2023).","journal-title":"J. Surg. Res."},{"issue":"4","key":"95735_CR56","first-page":"L769","volume":"277","author":"EJ Pulido","year":"1999","unstructured":"Pulido, E. J. et al. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation. Am. J. Physiol. 277(4), L769-776 (1999).","journal-title":"Am. J. Physiol."},{"issue":"6","key":"95735_CR57","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.jaci.2018.01.038","volume":"142","author":"H Rodriguez Cetina Biefer","year":"2018","unstructured":"Rodriguez Cetina Biefer, H. et al. Mast cells regulate CD4(+) T-cell differentiation in the absence of antigen presentation. J. Allergy Clin. Immunol. 142(6), 1894-1908e1897 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"95735_CR58","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00134-003-1738-7","volume":"29","author":"M Scharte","year":"2003","unstructured":"Scharte, M. et al. Nicotinamide increases systemic vascular resistance in ovine endotoxemia. Intensive Care Med. 29(6), 989\u2013994 (2003).","journal-title":"Intensive Care Med."},{"issue":"2","key":"95735_CR59","first-page":"128","volume":"55","author":"J Selli","year":"2023","unstructured":"Selli, J., Vural Keles, D., Keles, O. N., Celik, M. & Yetim, Z. Nicotinamide riboside preserves ovarian injury in experimental sepsis model in rats. Eurasian J. Med. 55(2), 128\u2013134 (2023).","journal-title":"Eurasian J. Med."},{"issue":"4","key":"95735_CR60","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/archsurg.1966.01330040026003","volume":"93","author":"RC Shaw","year":"1966","unstructured":"Shaw, R. C. et al. A bioassay of treatment of hemorrhagic shock. 3. Effects of a saline solution, ascorbic acid, and nicotinamide upon the toxicity of endotoxin for rats. Arch. Surg. 93(4), 562\u2013566 (1966).","journal-title":"Arch. Surg."},{"key":"95735_CR61","doi-asserted-by":"publisher","first-page":"42279","DOI":"10.1038\/srep42279","volume":"7","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gbetagamma\/PKC\/ERK1\/2 pathway and heterologous receptor desensitization. Sci. Rep. 7, 42279 (2017).","journal-title":"Sci. Rep."},{"issue":"8","key":"95735_CR62","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/ajcn\/30.8.1364","volume":"30","author":"IM Smith","year":"1977","unstructured":"Smith, I. M. & Burmeister, L. F. Biochemically assisted antibiotic treatment of lethal murine Staphylococcus aureus septic shock. Am. J. Clin. Nutr. 30(8), 1364\u20131368 (1977).","journal-title":"Am. J. Clin. Nutr."},{"key":"95735_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jss.2022.09.030","volume":"283","author":"Y Tian","year":"2023","unstructured":"Tian, Y. et al. Nicotinamide mononucleotide attenuates LPS-induced acute lung injury with anti-inflammatory, anti-oxidative and anti-apoptotic effects. J. Surg. Res. 283, 9\u201318 (2023).","journal-title":"J. Surg. Res."},{"issue":"5","key":"95735_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/01902148.2012.673049","volume":"38","author":"NS Umapathy","year":"2012","unstructured":"Umapathy, N. S. et al. beta-Nicotinamide adenine dinucleotide attenuates lipopolysaccharide-induced inflammatory effects in a murine model of acute lung injury. Exp. Lung Res. 38(5), 223\u2013232 (2012).","journal-title":"Exp. Lung Res."},{"issue":"1","key":"95735_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00024382-199807000-00003","volume":"10","author":"GM Wray","year":"1998","unstructured":"Wray, G. M., Hinds, C. J. & Thiemermann, C. Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin. Shock 10(1), 13\u201319 (1998).","journal-title":"Shock"},{"issue":"7","key":"95735_CR66","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm.2175","volume":"16","author":"H Wurtele","year":"2010","unstructured":"Wurtele, H. et al. Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat. Med. 16(7), 774\u2013780 (2010).","journal-title":"Nat. Med."},{"key":"95735_CR67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fmicb.2019.00595","volume":"10","author":"X Xing","year":"2019","unstructured":"Xing, X. et al. Effect of nicotinamide against Candida albicans. Front. Microbiol. 10, 595 (2019).","journal-title":"Front. Microbiol."},{"issue":"5","key":"95735_CR68","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/SHK.0000000000000225","volume":"42","author":"W Xu","year":"2014","unstructured":"Xu, W. et al. Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury. Shock 42(5), 440\u2013447 (2014).","journal-title":"Shock"},{"issue":"1","key":"95735_CR69","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/21505594.2022.2119656","volume":"13","author":"Y Yan","year":"2022","unstructured":"Yan, Y., Liao, Z., Shen, J., Zhu, Z. & Cao, Y. Nicotinamide potentiates amphotericin B activity against Candida albicans. Virulence 13(1), 1533\u20131542 (2022).","journal-title":"Virulence"},{"issue":"8","key":"95735_CR70","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41565-022-01137-w","volume":"17","author":"M Ye","year":"2022","unstructured":"Ye, M. et al. NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis. Nat. Nanotechnol. 17(8), 880\u2013890 (2022).","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"95735_CR71","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.phrs.2011.11.014","volume":"65","author":"H Yuan","year":"2012","unstructured":"Yuan, H. et al. Therapeutic benefits of the group B3 vitamin nicotinamide in mice with lethal endotoxemia and polymicrobial sepsis. Pharmacol. Res. 65(3), 328\u2013337 (2012).","journal-title":"Pharmacol. Res."},{"issue":"2","key":"95735_CR72","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/SHK.0000000000002153","volume":"60","author":"GJ Zhao","year":"2023","unstructured":"Zhao, G. J. et al. Supplementation with nicotinamide riboside attenuates T cell exhaustion and improves survival in sepsis. Shock 60(2), 238\u2013247 (2023).","journal-title":"Shock"},{"issue":"4","key":"95735_CR73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00024382-199604000-00005","volume":"5","author":"B Zingarelli","year":"1996","unstructured":"Zingarelli, B., Salzman, A. L. & Szabo, C. Protective effects of nicotinamide against nitric oxide-mediated delayed vascular failure in endotoxic shock: Potential involvement of polyADP ribosyl synthetase. Shock 5(4), 258\u2013264 (1996).","journal-title":"Shock"},{"issue":"2","key":"95735_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/intimm\/dxy068","volume":"31","author":"A Singhal","year":"2019","unstructured":"Singhal, A. & Cheng, C. Y. Host NAD+ metabolism and infections: Therapeutic implications. Int. Immunol. 31(2), 59\u201367 (2019).","journal-title":"Int. Immunol."},{"issue":"4","key":"95735_CR75","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/febs.15807","volume":"289","author":"MS Suchard","year":"2022","unstructured":"Suchard, M. S. & Savulescu, D. M. Nicotinamide pathways as the root cause of sepsis - an evolutionary perspective on macrophage energetic shifts. FEBS J. 289(4), 955\u2013964 (2022).","journal-title":"FEBS J."},{"issue":"1","key":"95735_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s42255-021-00507-3","volume":"4","author":"C Brenner","year":"2022","unstructured":"Brenner, C. Viral infection as an NAD(+) battlefield. Nat. Metab. 4(1), 2\u20133 (2022).","journal-title":"Nat. Metab."},{"issue":"2","key":"95735_CR77","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.32658","volume":"78","author":"X Guo","year":"2023","unstructured":"Guo, X. et al. NAD + salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity. Hepatology 78(2), 468\u2013485 (2023).","journal-title":"Hepatology"},{"issue":"1","key":"95735_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.34067\/KID.0006452020","volume":"2","author":"NH Raines","year":"2021","unstructured":"Raines, N. H. et al. Niacinamide may be associated with improved outcomes in COVID-19-related acute kidney injury: An observational study. Kidney 2(1), 33\u201341 (2021).","journal-title":"Kidney"},{"issue":"10","key":"95735_CR79","doi-asserted-by":"publisher","first-page":"e003141","DOI":"10.1136\/bmjgh-2020-003141","volume":"5","author":"C Escadafal","year":"2020","unstructured":"Escadafal, C. et al. Bacterial versus non-bacterial infections: A methodology to support use-case-driven product development of diagnostics. BMJ Glob. Health 5(10), e003141 (2020).","journal-title":"BMJ Glob. Health"},{"issue":"8","key":"95735_CR80","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801\u2013810 (2016).","journal-title":"JAMA"},{"issue":"14","key":"95735_CR81","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.2016.2691","volume":"315","author":"LA van Vught","year":"2016","unstructured":"van Vught, L. A. et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA 315(14), 1469\u20131479 (2016).","journal-title":"JAMA"},{"issue":"1","key":"95735_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BST20190029","volume":"48","author":"I Grondman","year":"2020","unstructured":"Grondman, I., Pirvu, A., Riza, A., Ioana, M. & Netea, M. G. Biomarkers of inflammation and the etiology of sepsis. Biochem. Soc. Trans. 48(1), 1\u201314 (2020).","journal-title":"Biochem. Soc. Trans."},{"issue":"Suppl 1","key":"95735_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/SHK.0b013e318181a343","volume":"30","author":"LF Poli-de-Figueiredo","year":"2008","unstructured":"Poli-de-Figueiredo, L. F., Garrido, A. G., Nakagawa, N. & Sannomiya, P. Experimental models of sepsis and their clinical relevance. Shock 30(Suppl 1), 53\u201359 (2008).","journal-title":"Shock"},{"issue":"4","key":"95735_CR84","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/sur.2016.021","volume":"17","author":"AJ Lewis","year":"2016","unstructured":"Lewis, A. J., Seymour, C. W. & Rosengart, M. R. Current murine models of sepsis. Surg. Infect. (Larchmt) 17(4), 385\u2013393 (2016).","journal-title":"Surg. Infect. (Larchmt)"},{"issue":"5","key":"95735_CR85","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas, J. & Hughes, C. C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172(5), 2731\u20132738 (2004).","journal-title":"J. Immunol."},{"key":"95735_CR86","doi-asserted-by":"publisher","first-page":"1061444","DOI":"10.3389\/fcimb.2022.1061444","volume":"12","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y. et al. Early intestinal microbiota changes in aged and adult mice with sepsis. Front. Cell. Infect. Microbiol. 12, 1061444 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"95735_CR87","volume-title":"Niacin","author":"S Djadjo","year":"2025","unstructured":"Djadjo, S. & Bajaj, T. Niacin (StatPearls, 2025)."},{"issue":"3","key":"95735_CR88","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cld.2007.06.010","volume":"11","author":"SS Bhardwaj","year":"2007","unstructured":"Bhardwaj, S. S. & Chalasani, N. Lipid-lowering agents that cause drug-induced hepatotoxicity. Clin. Liver Dis. 11(3), 597\u2013613 (2007).","journal-title":"Clin. Liver Dis."},{"issue":"2","key":"95735_CR89","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2006.07.014","volume":"192","author":"CD Meyers","year":"2007","unstructured":"Meyers, C. D., Liu, P., Kamanna, V. S. & Kashyap, M. L. Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush. Atherosclerosis 192(2), 253\u2013258 (2007).","journal-title":"Atherosclerosis"},{"issue":"6","key":"95735_CR90","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bcp.2012.06.020","volume":"84","author":"Z Li","year":"2012","unstructured":"Li, Z. et al. Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice. Biochem. Pharmacol. 84(6), 821\u2013829 (2012).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"95735_CR91","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1038\/s41467-019-12055-2","volume":"10","author":"A Manago","year":"2019","unstructured":"Manago, A. et al. Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation. Nat. Commun. 10(1), 4116 (2019).","journal-title":"Nat. Commun."},{"key":"95735_CR92","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fonc.2020.00358","volume":"10","author":"V Audrito","year":"2020","unstructured":"Audrito, V., Messana, V. G. & Deaglio, S. NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation. Front. Oncol. 10, 358 (2020).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95735-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:10:04Z","timestamp":1744492204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95735-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95735"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95735-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"20 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12621"}}